MétaCan
Menu
Retour à la cohorte
Enregistrement W2148287035 · doi:10.1001/jamaoncol.2015.0735

The Global Burden of Cancer 2013

2015· article· en· W2148287035 sur OpenAlexafffund
Christina Fitzmaurice, Daniel Dicker, Amanda Pain, Hannah Hamavid, Maziar Moradi‐Lakeh, Michael F MacIntyre, Christine A. Allen, Gillian M Hansen, Rachel Woodbrook, Charles Wolfe, Randah R Hamadeh, Ami R. Moore, Andrea Werdecker, Bradford D. Gessner, Braden Te Ao, Brian J. McMahon, Chanté Karimkhani, Chuanhua Yu, Graham Cooke, David C. Schwebel, David O. Carpenter, David M. Pereira, Denis Nash, Dhruv S Kazi, Diego De Leo, Dietrich Plaß, Kingsley Nnanna Ukwaja, George D. Thurston, Kim Yun Jin, Edgar P. Simard, Edward J Mills, Eun‐Kee Park, Ferrán Catalá-López, Gabrielle deVeber, Carolyn Gotay, Gulfaraz Khan, Hung Chak Ho, Itamar S Santos, Janet L Leasher, Jasvinder A. Singh, James Leigh, Jost B. Jonas, Juan Sanabria, Justin Beardsley, Kathryn H. Jacobsen, Ken Takahashi, Richard C. Franklin, Luca Ronfani, Marcella Montico, Luigi Naldi, Marcello Tonelli, Johanna M. Geleijnse, Max Petzold, Mark G. Shrime, Mustafa Z Younis, Naohiro Yonemoto, Nicholas J. K. Breitborde, Paul Yip, Farshad Pourmalek, Paulo A. Lotufo, Alireza Esteghamati, Graeme J. Hankey, Raghib Ali, Raimundas Lunevičius, Reza Malekzadeh, Robert P Dellavalle, Robert Weintraub, Robyn Lucas, Roderick J. Hay, David Rojas‐Rueda, Ronny Westerman, Sadaf G Sepanlou, Sandra Nolte, Scott B. Patten, Scott Weichenthal, Semaw Ferede Abera, Seyed-Mohammad Fereshtehnejad, Ivy Shiue, Tim Driscoll, Tommi Vasankari, Ubai Alsharif, Vafa Rahimi‐Movaghar, Vasily Vlassov, Wagner Marcenes, Yohannes Adama Melaku, Yuichiro Yano, Al Artaman, Ismael Campos‐Nonato, Jennifer H MacLachlan, Ulrich Müeller, Daniel Kim, Matias Trillini, Babak Eshrati, Hywel C Williams, Kenji Shibuya, Rakhi Dandona, Kinnari Murthy, Azmeraw T. Amare, Carl Abelardo T. Antonio, Carlos A Castañeda-Orjuela, Coen H. van Gool, Francesco Saverio Violante, In‐Hwan Oh, Kebede Deribe, Kjetil Søreide, Luke D. Knibbs, Maia Kereselidze, Mark Green, Rosario Cárdenas, Nobhojit Roy, Taavi Tillmann, Yongmei Li, Hans Krueger, Lorenzo Monasta, Subhojit Dey, Sara Sheikhbahaei, Nima Hafezi‐Nejad, G Anil Kumar, Chandrashekhar T Sreeramareddy, Lalit Dandona, Haidong Wang, Ali H. Mokdad, Joshua A. Salomon, Rafael Lozano, Theo Vos, Mohammad H. Forouzanfar, Alan D López, Christopher J L Murray, Mohsen Naghavi

Notice bibliographique

RevueJAMA Oncology · 2015
Typearticle
Langueen
DomaineMedicine
ThématiqueGlobal Cancer Incidence and Screening
Établissements canadiensUniversity of CalgaryUniversity of British ColumbiaUniversity of TorontoHealth CanadaUniversity of Ottawa
Organismes subventionnairesUniversity of Colorado School of Medicine, Anschutz Medical CampusNational Institute of Environmental Health SciencesBarts and The London School of Medicine and DentistryWageningen University and ResearchInstitute of Infection and ImmunityAllerganMekelle UniversityAddis Ababa UniversityUniversità di BolognaNational Center of Neurology and PsychiatryUniversitetet i BergenSahlgrenska AkademinUniversity of Hong KongNorthwestern UniversityUniversiti Tunku Abdul RahmanGöteborgs UniversitetKyung Hee UniversityNational Research University Higher School of EconomicsUniversity of QueenslandPublic Health Foundation of IndiaNational Heart, Lung, and Blood InstituteTehran University of Medical Sciences and Health ServicesAustralian National UniversityGenentechUniversity of OxfordJames Cook UniversityWellcome TrustUniversity College LondonIstituto di Ricerche Farmacologiche Mario Negri - IRCCSNational Institute for Health and Care ResearchUniversity of the PhilippinesInstitute for Health Metrics and EvaluationNorthumbria UniversityFaculty of Medicine and Health, University of SydneyPhilipps-Universität MarburgHealth CanadaHarvard UniversityJackson State UniversityKarolinska InstitutetBill and Melinda Gates FoundationRijksuniversiteit GroningenFaculty of Medicine, University of British ColumbiaNational Institutes of HealthRegeneron PharmaceuticalsArak University of Medical SciencesU.S. Department of Veterans Affairs
Mots-clésMedicineCancerMEDLINEInternal medicine

Résumé

récupéré en direct d'OpenAlex

IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs. FINDINGS: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries. CONCLUSIONS AND RELEVANCE: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,002
score de la tête « metaresearch » (Gemma)0,004
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: aucune
Score de désaccord entre enseignants0,095
Score d'incertitude au seuil0,319

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0020,004
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0020,004
Études des sciences et des technologies0,0010,001
Communication savante0,0040,002
Science ouverte0,0010,003
Intégrité de la recherche0,0020,003
Charge utile insuffisante (le modèle a refusé de juger)0,0950,046

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,110
Tête enseignante GPT0,429
Écart entre enseignants0,320 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations2 758
Publié2015
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueJAMA OncologyMême sujetGlobal Cancer Incidence and ScreeningTravaux en français237 207